| __timestamp | Celldex Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 49315000 |
| Thursday, January 1, 2015 | 33837000 | 75043000 |
| Friday, January 1, 2016 | 35979000 | 83749000 |
| Sunday, January 1, 2017 | 25003000 | 122682000 |
| Monday, January 1, 2018 | 19269000 | 207761000 |
| Tuesday, January 1, 2019 | 15426000 | 284812000 |
| Wednesday, January 1, 2020 | 14456000 | 317875000 |
| Friday, January 1, 2021 | 20488000 | 282660000 |
| Saturday, January 1, 2022 | 27195000 | 451421000 |
| Sunday, January 1, 2023 | 30914000 | 481871000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Sarepta Therapeutics, Inc. and Celldex Therapeutics, Inc., from 2014 to 2023. Over this period, Sarepta's SG&A expenses surged by approximately 878%, reflecting its aggressive expansion and strategic investments. In contrast, Celldex's expenses grew by about 50%, indicating a more conservative approach.
This financial trajectory highlights the differing strategies of these biotech firms, offering insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Vertex Pharmaceuticals Incorporated vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Genmab A/S or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. or Halozyme Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends